From fingerprinting, we create a novel library of compounds from which we obtain five derived compounds that have higher MAO-B affinity and lead-likeness potential, from such we found that 6 APP may be the most active compound (MAO-B, NO, and CYP450) and may be subjected experimental test against PD. Here, APP is linked to Parkinson disease.